- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03270436
Diabetes Prevention Program Lifestyle Intervention in the Marshallese Population
Study Overview
Status
Conditions
Detailed Description
Background and Rationale
Disparities in type 2 diabetes, pre-diabetes, and obesity among the Marshallese and Pacific Islanders.
The Marshallese are a Pacific Islander population experiencing significant health disparities, with some of the highest documented rates of type 2 diabetes of any population group in the world. Our review of local, national, and international data sources found estimates of diabetes in the Marshallese population (those living in the US and in the Republic of the Marshall Islands) ranging from 20% to 50%, compared to 8.3% for the US population and 4% worldwide. While national prevalence data are limited, 23.7% of Pacific Islanders surveyed by the Centers for Disease Control and Prevention (CDC) in 2010 reported a diagnosis of type 2 diabetes, more than all other racial/ethnic groups. Our pilot research, which includes health screenings with the Marshallese community in northwest Arkansas (n=398), documented extremely high incidence of diabetes (38.4%) and pre-diabetes (32.6%). Our pilot data also revealed similar disparities in one of the strongest risk factors for diabetes-obesity-with 90% of Marshallese participants classified as overweight or obese. Thirty-two percent of those who had pre-diabetes were also overweight or obese. Further compounding these significant disparities in diabetes prevalence and related risk factors, research indicates that Pacific Islanders living in the US are less likely than other racial/ethnic groups to receive preventative or diagnostic treatment, or diabetes education.
Reducing disparities by reducing weight. Overweight/obesity is considered the strongest modifiable risk factor for type 2 diabetes, and even a modest reduction in weight (5-10%) can be clinically meaningful.
Specific aim. Our aim is to compare the effectiveness of achieving weight loss between two Diabetes Prevention Program (DPP) Lifestyle Interventions - the faith-based Wholeness, Oneness, Righteousness, Deliverance (WORD) DPP, and the Pacific Islander culturally-adapted Partnership for Improving Lifestyle Interventions (PILI) DPP - in the Marshallese population using a cluster randomized controlled trial (cRCT).
Study design. The study design is a comparative effectiveness cRCT conducted in church settings or other community setting convenient to the participant group. Churches were selected as the primary setting based on Marshallese stakeholder input.
Randomized participant assignment. Randomization will occur at the church cluster level, with 1:1 assignment of churches to each arm. Churches and community based participant groups will be blocked (i.e., grouped into similar units) according to geographic region and approximate number of adult church members. Randomization will be conducted by a biostatistician or designated investigator, who will have no interactions with potential participants and has no supervisory role with study staff responsible for recruiting, consent, and intervention process.
Recruitment and Consent
Church-based recruitment is specified by stakeholders as culturally appropriate and the community's preferred recruitment method. During recruitment, Marshallese study staff will give presentations and distribute study information in English and Marshallese. Those who express interest will complete an eligibility screener, to determine eligibility. All study information and consent materials will be provided in English and/or Marshallese based upon the participants' preferences. Eligible participants will be provided a copy of the consent to review, and participants will have the opportunity to ask questions, consent, and enroll in the study. The consent process will include providing information to the potential participants and the opportunity to have bilingual Marshallese staff answer questions regarding study participation. The consent document will be given to the participant, and the informed consent process will be documented in the participant's research record.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Fayetteville, Arkansas, United States, 72703
- University of Arkansas for Medical Sciences Northwest
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Self reported Marshallese
- 18 years of age or older
- BMI greater than or equal to 25
Exclusion Criteria:
- A clinically significant medical condition likely to impact weight (cancer, HIV/AIDS, etc.)
- Currently pregnant or breastfeeding an infant who is 6 months old or younger
- Have any condition that makes it unlikely that the participant will be able to follow the protocol, such as terminal illness, plans to move out of the area within 6 months, an inability to finish the intervention, etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Wholeness, Oneness, Righteousness, Deliverance Diabetes Prevention Program
The Wholeness, Oneness, Righteousness, Deliverance Diabetes Prevention Program (WORD DPP) is a faith-based diabetes prevention curriculum that teaches participants to connect faith and health to have a healthy weight, eat healthy, and be physically active.
The WORD DPP includes 16 modules that are intended to be delivered over a 24 week period, each module approximately 90 minutes in length.
The first 8 modules are intended to be delivered weekly.
The last 8 modules are intended to be delivered every other week.
Participants in the WORD DPP will be encouraged to maintain a daily weight, nutrition, physical activity and prayer log.
|
Faith based diabetes curriculum that teaches participants to connect faith and health.
|
|
EXPERIMENTAL: Partnership for Improving Lifestyle Intervention Diabetes Prevention Program
The Partnership for Improving Lifestyle Intervention Diabetes Prevention Program (PILI DPP) is a family and community based diabetes prevention curriculum that teaches participants to engage their social support (family and community) to have a healthy weight, eat healthy, and be physically active.
The PILI DPP includes 14 modules that are intended to be delivered over a 24 week period and each module approximately 90 minutes in length.
The first 4 modules are intended to be delivered weekly.
The last 10 modules are intended to be delivered every other week.
Participants will be encouraged to track their weight, physical activity, and their nutrition in a log on a daily basis.
|
Family and community based diabetes prevention curriculum that teaches participants to engage their social support to have a healthy weight.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean Body Weight (kg)
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in mean body weight (kg) from baseline to immediate post intervention and 6 months post-intervention.
Participant weight (without shoes) was measured in light clothing using a calibrated digital scale at each time point.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean HbA1c (%)
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in mean HbA1c (NGSP %) from baseline to immediate post-intervention and 6 months post-intervention.
A Siemens analyzer (point of care) was utilized to calculate HbA1c levels for each participant at each time point.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
|
Change in Mean Systolic Blood Pressure (mmHg)
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in mean systolic blood pressure (mmHg) from baseline to immediate post-intervention and 6 months post-intervention.
Blood pressure was measured at each time point with a sphygmomanometer and stethoscope or digital blood pressure device, with participants seated and arm elevated.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
|
Change in Mean Diastolic Blood Pressure (mmHg)
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in mean diastolic blood pressure (mmHg) from baseline to immediate post-intervention and 6 months post-intervention.
Blood pressure was measured at each time point with a sphygmomanometer and stethoscope or digital blood pressure device, with participants seated and arm elevated.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
|
Change in Sugar-sweetened Beverage Consumption
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in participants' sugar-sweetened beverage (SSB) consumption from baseline to immediate post-intervention and 6 months post-intervention.
This self-report measure assessed participants' SSB consumption over the past 30 days using two questions from 'Module 14: Sugar Sweetened Beverages' of the Center for Disease Control and Prevention's Behavioral Risk Factor Surveillance System (BRFSS).
Participants could respond in number of times per day, per week, or per month.
Responses for each question were converted to number of times per day (i.e., self-reported times per week divided by 7 or self-reported times per month divided by 30), resulting in two measures: number times soda was consumed per day and number of times sugar-sweetened fruit drinks, sweet tea, and sports drinks were consumed per day.
Per BRFSS guidelines, these two measures were added together to create a total daily SSB consumption rate.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
|
Change in Fruit and Vegetable Consumption
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in participants' fruit and vegetable consumption from baseline to immediate post-intervention and 6 months post-intervention.
This self-report measure assessed participants' fruit and vegetable consumption over the past three months using three items adapted from: Shannon J, Kristal AR, Curry SJ, Beresford SA.
Application of a behavioral approach to measuring dietary change: the fat- and fiber-related diet behavior questionnaire.
Cancer Epidemiol Biomarkers Prev.
1997;6(5):355-361.
Each of the three items was scored as Often=2; Sometimes=1; Never=0.
Items were summed to create a scale score, giving a possible range of scores of 0-6, with higher scores indicating more frequent consumption of fruits and vegetables.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
|
Change in Proportion of Participants Engaging in Sufficient Levels of Physical Activity
Time Frame: Baseline, immediate post-intervention, 6 months post-intervention
|
Change in proportion of participants engaging in sufficient levels of physical activity (PA) from baseline to immediate post-intervention and 6 months post-intervention.
This measure assessed participants' frequency of engaging in both moderate and vigorous PA over the past month (>4 times a week, 2-4 times a week, about once a week, etc.).
This measure was adapted to include relevant cultural examples of PA from the Dietary Approaches to Stop Hypertension 2 Brief Physical Activity Questionnaire (https://biolincc.nhlbi.nih.gov/media/studies/dashsodium/Forms_Manual.pdf?link_time=2018-11-13_18:06:05.776099).
Both items used a 4-point response scale: 1) Rarely or Never; 2) Once a week; 3) 2-4 times a week; and 4) More than 4 times a week.
Each 4-point scale for moderate PA and vigorous PA was weighted: 0=Rarely or Never; 1=Once a week; 2=2-4 times a week; and 4=More than 4 times a week.
The weights were then summed and dichotomized as follows: ≥4 = sufficient PA and <4 = insufficient PA.
|
Baseline, immediate post-intervention, 6 months post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Eating Habits Self-efficacy Score
Time Frame: Baseline, Immediate post-intervention, 6 months post-intervention
|
Change in eating habits self-efficacy from baseline to immediate post-intervention and 6 months post-intervention (12 months post-initiation of the intervention).
This self-report measure assessed participants' self-efficacy related to their ability to make healthy eating decisions in the face of real or perceived barriers (e.g. while at social events, while watching television, etc.).
This 7-item measure was adapted from items in the original Weight Efficacy Life-Style (WEL) Questionnaire (Clark MM, Abrams DB, Niaura RS, et al.
Self-efficacy in weight management.
J Consult Clin Psychol.
1991;59(5):739-744).
Each of the 7 items are measured via 3 response options ("Yes/Completely Sure"=2; "Maybe/Not Sure"=1; and "No/Not Sure at All"=0), giving a possible range of scores of 0-14, with higher scores indicating higher self-efficacy for making healthy eating decisions in spite of barriers.
|
Baseline, Immediate post-intervention, 6 months post-intervention
|
|
Change in Physical Activity Self-efficacy
Time Frame: Baseline, Immediate post-intervention, 6 months post-intervention
|
Change in physical activity self-efficacy from baseline to immediate post-intervention and 6 months post-intervention (12 months post-initiation of the intervention).
This self-report measure assessed participants' self-efficacy for exercising in the face of real or perceived barriers (e.g., bad weather, exercising alone, etc.).
This 9-item measure was adapted from the Self-Efficacy for Exercise (SEE) Scale (Resnick B, Jenkins LS.
Testing the reliability and validity of the Self-Efficacy for Exercise scale.
Nurs Res.
2000;49(3):154-159.
& Resnick B, Luisi D, Vogel A, Junaleepa P. Reliability and validity of the Self-Efficacy for Exercise and Outcome Expectations for Exercise Scales with minority older adults.
J Nurs Measurement.
2004; 12(3):235-247.)
Each of the 9 items are measured via 3 response options ("Yes/Completely Sure"=2; "Maybe/Not Sure"=1; and "No/Not Sure at All"=0), giving a possible range of scores of 0-18, with higher scores indicating higher self-efficacy.
|
Baseline, Immediate post-intervention, 6 months post-intervention
|
|
Change in Perceived Family Support for Exercise and Dietary Habits
Time Frame: Baseline, Immediate post-intervention, 6 months post-intervention
|
Change in perceived family support for exercise and dietary habits from baseline to immediate post-intervention and 6 months post-intervention.
This self-report measure was adapted to examine changes in perceived family support for engaging in healthy exercise and dietary habits.
This measure consists of a 6-item scale adapted from: Gruber KJ.
Social support for exercise and dietary habits among college students.
Adolescence.
2008;43(171):557-575.
Each of the 6 items are measured via 3 response options ("Often"=2; "Sometimes"=1; and "Never"=0), giving a possible range of scores of 0-12, with higher scores indicating higher perceived family support for exercising and eating healthier.
|
Baseline, Immediate post-intervention, 6 months post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 207034
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on Wholeness, Oneness, Righteousness, Deliverance Diabetes Prevention Program
-
Montana State UniversityCompletedDiabetes Mellitus, Type 2United States
-
Baylor Research InstituteUniversity of North Texas Health Science CenterCompletedObesity | Pre-diabetesUnited States
-
The University of Texas Medical Branch, GalvestonWithdrawnHypertension | Prediabetic State | Overweight or Obesity | Gestational Weight Gain
-
Norwegian University of Science and TechnologyKathmandu University School of Medical SciencesCompleted
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHyperglycemia | Obesity | Overweight | Weight Loss | PreDiabetes | Prediabetic State | Impaired Glucose Tolerance | Glucose, High Blood | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryUnited States
-
University of Kansas Medical CenterKansas State University; National Institute of General Medical Sciences (NIGMS)CompletedWeight Loss | PreDiabetes | Lifestyle Risk ReductionUnited States
-
Washington State UniversityCompletedDiabetesUnited States
-
Washington State UniversityCompleted
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPreDiabetes | Type 2 Diabetes | Obesity, Childhood | Overweight and Obesity | Lifestyle, Healthy | Overweight, ChildhoodUnited States
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes